Seoul, South Korea - INUS Technology, Inc. will show the brand new release of its flagship quality inspection software, Rapidform XOV, at the EuroMold exhibition in Frankfurt, Germany December 1-4, 2010. EuroMold is the first public event where the new version's features will be displayed. The updates to Rapidform XOV2 SP2 make inspecting parts with a 3D scanner faster and easier, and bolster the software's industry-leading CAD interoperability and automation capabilities.
The Rapidform booth at EuroMold is in Hall 8.0, Stand F11. The entire Rapidform product line will be on display, including:
* Rapidform XOR, the only software that combines 3D scan data processing with a CAD solid modeling kernel to offer real reverse engineering
* Rapidform XOV, with brand new features for faster inspection and verification of parts from a 3D scanner
* Rapidform XOS, offering automated 3D scan data optimization and NURBS surface generation for non-CAD applications
Calvin Hur, CEO of INUS Technology, remarked "Our customers know that Rapidform is synonymous with progress and innovation, and we're keeping our reputation alive with the new developments in Rapidform XOV. We're excited to show these new updates, as well as our popular XOR and XOS software, to visitors at Euromold 2010. Our number one goal is to unlock the power of 3D scanning for everyone."
Visitors are encouraged to stop by the booth to learn more about 3D scanning, reverse engineering and inspection.
Nov 24, 2010
Popular Articles
- Automotive Tier-One Suppliers Adopt TPM for Faster, Automated Data Translations
- Autodesk Acquires T-Splines Modeling Technology Assets
- Infotech Enterprises's revenue Rs 2327.5mn for 3rd quarter ended December 31, 2008
- Femap® From Siemens PLM Software Now Sold Worldwide Through NEi Software's Reseller Network
- Sescoi's WorkNC 5-Axis and Auto 5 - a competitive advantage at ALLIO
- Visteon Technology Helps Drivers to Be More Aware of Surroundings
- New powerful functionalities for think3’s ThinkDesign 2009.1
- PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients
- Michael Schley named as 2008 ifma fellow
- MSC.Software Releases Marc 2010